【网学提醒】:本文主要为网上学习者提供慢性粒细胞白血病急变相关基因研究进展,希望对需要慢性粒细胞白血病急变相关基因研究进展网友有所帮助,学习一下吧!
资料包括: 论文(5页4252字)
说明:
关键词: 慢性粒细胞白血病(CML),cML急变,基因
慢性粒细胞白血病(CML)是一种起源于多能造血干细胞的血液系统恶性疾病。根据其临床进展,可分为慢性期(CP),加速期(AP)和急变期(BC)。加速期和急变期表现为分化受阻,不受髓细胞生成调节因子的调节。研究CML急变的分子机制一直成为国内外的研究热点。近年来,许多临床和实验观察都显示CML急变时涉及到许多基因的改变,现将研究现状综述如下。
1 BCR-ABL基因与CML急变
早在1960年Nowell和Hungerford就在CML患者的白血病细胞中发现了费城染色体(Ph染色体)。1973年,Rowley等应用染色体分带技术,证明Ph染色体是由于t(9;22)(q34.1;q11.21)而形成的。
位于9q34上的ABL原癌基因易位至22q11的BCR基因3′端,形成BCR-ABL融合基因,其产物为相对分子质量为210×103的BCR-ABL融合蛋白(p210)。与正常的ABL蛋白相比,p210有更强的酪氨酸蛋白激酶活性,在体外能使造血祖细胞转化。Daley等[1]在骨髓移植模型中,将人BCR-ABL基因导入小鼠骨髓细胞,再输入接受致死剂量照射的同系小鼠,结果在绝大多数受体小鼠产生了类似人CML的病变,这些研究肯定了p210在白血病发生中起直接作用。
目录:
1 BCR-ABL基因与CML急变
2 其他癌基因与CML急变
3 抑癌基因与CML急变
4 其他基因与CML急变
参考文献:
Daley GQ,van Etten RA,Baltimore D.Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome.Science,1990,247:824.
Schaefer-Rego K,Dudek H,Popenoe D,et al.CML patients in blast crisis have breakpoints localized to a specific region of the bcr.Blood,1987,70:448.
Morris SW,Daniel L,Ahmed CMI,et al.Relationship of bcr breakpoint to chronic phase duration,survival and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.Blood,1990,75:2035-2041.
Tanaka M,Yamazaki Y,Hattori M,et al.The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia.Leuk Res,1996,20:575-580.
Pane F,Frigeri F,Sindona M,et al.Neutrophilic-chronic myeloid leukemia:a distinct disease with a specific molecular marker(bcr/abl with C3/A2 junction).Blood,1996,88:2410-2414.
Gaiger A,Henn T,Geissler K,et al.Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.Blood,1995,86:2371-2378.
Wetzler M,Talpaz M,van Etten RA,et al.Subcellular localization of bcr,abl and bcr-abl proteins in normal and leukemia cells and correlation of expression with myeloid differentiation.J Clin Invest,1993,92:1925.
Bedi A,Zehnbauer B,Barber J,et al.Inhibition of apoptosis by bcr-abl in chronic myeloid leukemia.Blood,1994,83:2038-2044.
Kimura A,Nakata Y,Hyodo H,et al.Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukemia with myelofibrosis.Br J Haematol,1994,86:303-307.
Carapeti M,Soede BA,Hochhaus A,et al.Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia.Leukemia,1997,11:1005-1008.
Tanaka K,Takauchi K,Takechi M,et al.High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.Leuk Lymph,1994,13:317-322.
Kubonishi I,Asahi Y,Machida H,et al.PTHrP-mediated hypercalcaemia in a case of CML blast crisis.Br J Haematol,1997,96:165-167.
Gaidano G,Guerrasio A,Serra A,et al.Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.leukemia,1994,8(Suppl):27-29.
Handa H,Hegde UP,Kotelnikov VM,et al.Bcl-2 and c-myc expression,cell cycle kinetics and apoptosis during the progression of chronic myeloid leukemia from diagnosis to blast crisis.Leuk Res,1997,21:479-489.
[15] Mitani K.Molecular mechanism of blastic crisis in chronic myelocytic leukemia. Leukemia, 1997,3(Suppl):503-505.
[16] Fenaux P.The clinical significance of mutations of the P53 tumor suppresser gene in hematological malignancies.Br J Haematol,1997,98:502-511.
[17] Nakai H,Kaneko H,Horiike S.Multiple aberrant splicing of the P53 transcript without genomic mutations around exon-intron junctions in a case of CML in blast crisis——a possible novel mechanism of P53 inactivation.Br J Haematol,1994,87:839-842.
[18] Serra I,Gottardi E,Ragione FD,et al.Involvement of the cyclin-dependent kinase-4 inhibitor(CDNK2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukemia.Br J Haematol,1995,91:625-629.
[19] Dong WF,Heng HH,Lowsky R,et al.Cloning,expression,and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene,hLim-1.DNA Cell Biol,1997,16:671-678.
[20] Schimamata T,Ohyashiki K,Ohyshiki JH,et al.The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.Blood,1995,86:3173-3180.
[21] Mills KI,Guina BA,Walsh VA,et al.Increasing methylation of the calcitonin gene in CML patients.Leuk Res,1996,20:771-775.
[22] Kiyoi H,Fukutani H,Yamauchi T,et al.Continuing immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crisis after bone marrow transplantation.Leukemia,1995,9:265-270.